Back to Weight Loss
Weekly GLP-1 injectable

Weekly GLP-1 injectable

Wegovy® the brand name for Semaglutide, a type of medication called GLP-1s. GLP-1s are a class of medical treatments for weight loss and diabetes. They mimic the GLP-1 hormone that is naturally released in the gastrointestinal tract in response to eating.


The active ingredient in Wegovy®, Semaglutide has been linked to deliver:

  • Less hunger
  • Fewer food cravings
  • Better control of eating 
  • Reduced preference for high-fat foods

All this can lead to eating fewer calories and as a result, significant weight loss.


A 2021 study conducted with almost 2,000 adults without diabetes, showed that after 68 weeks, participants taking a weekly Semaglutide injection lost an average of almost 15% of their body weight. This was alongside some lifestyle changes, like improving their diet and getting regular physical activity. [1]


[1] The New England Journal of Medicine February 2021: DOI: 10.1056/NEJMoa203218

Join the OVA community

Stay informed on wellness, weight management, and new treatments.
By subscribing you agree to with our Privacy Policy

ova logoDISCLAIMER: OVA is a digital health platform which facilitates the provision of healthcare services by connecting its users with licensed medical professionals, pharmacies and other licensed healthcare institutions. OVA does not prescribe, store or dispense any medication. OVA itself is neither a licensed clinic nor a licensed pharmacy. For further information, refer to our terms of use.
Contact+60 3 2771 2755hello@getova.com.my

Orbit Healthcare and Services Sdn Bhd 

No. 23, Jalan Para U8/103, Bukit Jelutong, Shah Alam, Selangor, Malaysia

© OVA 2026. All Rights Reserved.